Cargando…
The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
Currently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern inc...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526810/ https://www.ncbi.nlm.nih.gov/pubmed/36184631 http://dx.doi.org/10.1038/s41467-022-33549-6 |
_version_ | 1784800959088558080 |
---|---|
author | Sridhar, Saranya Chicz, Roman M. Warren, William Tartaglia, Jim Savarino, Stephen Gurunathan, Sanjay Toussaint, Jean-Francois |
author_facet | Sridhar, Saranya Chicz, Roman M. Warren, William Tartaglia, Jim Savarino, Stephen Gurunathan, Sanjay Toussaint, Jean-Francois |
author_sort | Sridhar, Saranya |
collection | PubMed |
description | Currently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern including the most prevalent variant for the coming season. We here discuss recent preclinical and clinical data on COVID vaccine antigens that are potential candidates for an updated vaccine. |
format | Online Article Text |
id | pubmed-9526810 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95268102022-10-03 The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 Sridhar, Saranya Chicz, Roman M. Warren, William Tartaglia, Jim Savarino, Stephen Gurunathan, Sanjay Toussaint, Jean-Francois Nat Commun Comment Currently approved COVID vaccines are designed using the spike antigen derived from the ancestral strain, but health authorities are recommending changes to the vaccine strain to combat emerging variants. The goal is to ensure that next generation vaccines can tackle multiple variants of concern including the most prevalent variant for the coming season. We here discuss recent preclinical and clinical data on COVID vaccine antigens that are potential candidates for an updated vaccine. Nature Publishing Group UK 2022-10-02 /pmc/articles/PMC9526810/ /pubmed/36184631 http://dx.doi.org/10.1038/s41467-022-33549-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Comment Sridhar, Saranya Chicz, Roman M. Warren, William Tartaglia, Jim Savarino, Stephen Gurunathan, Sanjay Toussaint, Jean-Francois The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 |
title | The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 |
title_full | The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 |
title_fullStr | The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 |
title_full_unstemmed | The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 |
title_short | The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022 |
title_sort | potential of beta variant containing covid booster vaccines for chasing omicron in 2022 |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526810/ https://www.ncbi.nlm.nih.gov/pubmed/36184631 http://dx.doi.org/10.1038/s41467-022-33549-6 |
work_keys_str_mv | AT sridharsaranya thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT chiczromanm thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT warrenwilliam thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT tartagliajim thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT savarinostephen thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT gurunathansanjay thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT toussaintjeanfrancois thepotentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT sridharsaranya potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT chiczromanm potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT warrenwilliam potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT tartagliajim potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT savarinostephen potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT gurunathansanjay potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 AT toussaintjeanfrancois potentialofbetavariantcontainingcovidboostervaccinesforchasingomicronin2022 |